Vermillion Profit Margin 2006-2019 | VRML

Current and historical gross margin, operating margin and net profit margin for Vermillion (VRML) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Vermillion net profit margin as of March 31, 2019 is -381.57%.
Vermillion Annual Profit Margins
Vermillion Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.083B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $114.479B 25.04
Intuitive Surgical (ISRG) United States $59.521B 54.85
Edwards Lifesciences (EW) United States $39.100B 39.07
IDEXX Laboratories (IDXX) United States $24.408B 64.03
Fresenius Medical Care AG KGaA (FMS) Germany $24.241B 15.93
Teleflex (TFX) United States $15.301B 33.15
Olympus (OCPNY) Japan $15.078B 112.82
SONOVA HOLDING (SONVY) Switzerland $14.501B 0.00
Sysmex ADR (SSMXY) Japan $14.145B 38.13
DexCom (DXCM) United States $13.644B 267.59
Hologic (HOLX) United States $12.620B 20.29
STERIS (STE) Ireland $12.544B 30.34
Varian Medical Systems (VAR) United States $12.269B 31.30
ABIOMED (ABMD) United States $11.491B 69.90
Masimo (MASI) United States $8.109B 49.69
Penumbra (PEN) United States $5.895B 249.54
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.153B 38.83
Integra LifeSciences Holdings (IART) United States $4.555B 21.40
Globus Medical (GMED) United States $4.118B 25.68
Tandem Diabetes Care (TNDM) United States $3.627B 0.00
LivaNova (LIVN) United Kingdom $3.564B 23.23
Wright Medical Group (WMGI) Netherlands $3.321B 658.25
Cantel Medical (CMD) United States $3.301B 33.49
Glaukos (GKOS) United States $2.752B 0.00
Integer Holdings (ITGR) United States $2.651B 19.54
Nihon Kohden (NHNKY) Japan $2.366B 23.80
AVANOS MEDICAL, INC (AVNS) United States $1.989B 31.47
Nevro (NVRO) United States $1.941B 0.00
Inogen (INGN) United States $1.360B 30.11
OPKO Health (OPK) United States $1.293B 0.00
Silk Road Medical (SILK) United States $1.252B 0.00
Veracyte (VCYT) United States $1.187B 0.00
CryoLife (CRY) United States $1.093B 108.41
Tactile Systems Technology (TCMD) United States $1.043B 153.92
Accelerate Diagnostics (AXDX) United States $1.041B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.966B 27.98
Mesa Laboratories (MLAB) United States $0.914B 42.99
Pacific Biosciences Of California (PACB) United States $0.901B 0.00
Luminex (LMNX) United States $0.894B 116.94
ViewRay (VRAY) United States $0.887B 0.00
Natus Medical (BABY) United States $0.887B 20.53
AngioDynamics (ANGO) United States $0.796B 26.10
AxoGen (AXGN) United States $0.764B 0.00
Fluidigm (FLDM) United States $0.752B 0.00
Quotient (QTNT) Switzerland $0.693B 0.00
Intersect ENT (XENT) United States $0.640B 0.00
OrthoPediatrics (KIDS) United States $0.559B 0.00
Corindus Vascular Robotics (CVRS) United States $0.544B 0.00
Si-Bone (SIBN) United States $0.488B 0.00
GenMark Diagnostics (GNMK) United States $0.356B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.351B 18.81
Accuray (ARAY) United States $0.317B 0.00
RTI Surgical (RTIX) United States $0.312B 38.36
TransEnterix (TRXC) United States $0.306B 0.00
Semler Scientific (SMLR) United States $0.291B 57.78
SeaSpine Holdings (SPNE) United States $0.239B 0.00
Neuronetics (STIM) United States $0.231B 0.00
ConforMIS (CFMS) United States $0.231B 0.00
IRadimed (IRMD) United States $0.202B 38.53
Alphatec Holdings (ATEC) United States $0.201B 0.00
CRH Medical (CRHM) Canada $0.199B 69.00
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.172B 0.00
Second Sight Medical Products (EYES) United States $0.101B 0.00
Ekso Bionics Holdings (EKSO) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
T2 Biosystems (TTOO) United States $0.076B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
Apollo Endosurgery (APEN) United States $0.069B 0.00
Spectral Diagnostics (EDTXF) Canada $0.066B 0.00
Helius Medical Technologies (HSDT) United States $0.055B 0.00